EUVIMEDEUVIMED entdecken
Crossref

endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies

M Xian, C Wang, L Zhang

Rhinology Journal · 2025

DOI: 10.4193/rhin25.291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rhinology Journal, 2025. Verfasst von M Xian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Rhinitis, Sinusitis, Biological Products, Nasal Polyps.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We read with great interest the recent study by Fieux et al. (1), which developed an evaluation model based on clinical practices, public health insurance, and private insurance systems in France. Through rigorous cost-effectiveness analysis, the authors concluded that initiating biologic therapy in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) without previous endoscopic sinus surgery (ESS) imposes excessive economic burdens. This finding aligns with the current guideline regarding the indications for biological treatment in CRSwNP, which reserves biologics primarily for patients with prior ESS history.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinitisSinusitisBiological ProductsNasal PolypsHumansCost-Benefit AnalysisChronic DiseaseFrance

Substanzen

Biological Products

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
  • Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China;Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.

Zitieren

APA

Xian, M., Wang, C., & Zhang, L. (2025). endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies. Rhinology Journal. https://doi.org/10.4193/rhin25.291

Vancouver

Xian M, Wang C, Zhang L. endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies. Rhinology Journal. 2025. doi:10.4193/rhin25.291

BibTeX
@article{Xian2025,
  author = {Xian, M and Wang, C and Zhang, L},
  title = {endoscoRegional disparities in cost-effectiveness of biologics for CRSwNP warrant tailored treatment strategies},
  journal = {Rhinology Journal},
  year = {2025},
  doi = {10.4193/rhin25.291}
}
Kostenlos starten →